Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease.
BACKGROUND: Asthma and chronic obstructive pulmonary disease (COPD) display features of overlap in airway physiology and airway inflammation. Whether inflammatory phenotypes in airway disease describe similar mediator expression is unknown. OBJECTIVES: To explore the relationship of airway inflammat...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|
| _version_ | 1797079176034910208 |
|---|---|
| author | Bafadhel, M McCormick, M Saha, S McKenna, S Shelley, M Hargadon, B Mistry, V Reid, C Parker, D Dodson, P Jenkins, M Lloyd, A Rugman, P Newbold, P Brightling, C |
| author_facet | Bafadhel, M McCormick, M Saha, S McKenna, S Shelley, M Hargadon, B Mistry, V Reid, C Parker, D Dodson, P Jenkins, M Lloyd, A Rugman, P Newbold, P Brightling, C |
| author_sort | Bafadhel, M |
| collection | OXFORD |
| description | BACKGROUND: Asthma and chronic obstructive pulmonary disease (COPD) display features of overlap in airway physiology and airway inflammation. Whether inflammatory phenotypes in airway disease describe similar mediator expression is unknown. OBJECTIVES: To explore the relationship of airway inflammation and cytokine and chemokine expression in asthma and COPD. METHODS: Subjects with asthma and COPD (n = 54 and n = 49) were studied. Clinical characteristics and sputum were collected at entry into the study. A 2-step sputum processing method was performed for supernatant and cytospin preparation. Meso Scale Discovery and Luminex platforms were used to measure cytokines, chemokines and matrix metalloproteinase levels. RESULTS: Analytes sensitive to dithiothreitol (DTT) that had increased recovery in the 2-step sputum process were IL-1β, 4, 5, 10, 13, IFN-γ, TNFRI, GM-CSF, CCL2, 3, 4, 5, 13 and 17. There was a differential expression in IL-8, TNFRI and TNFRII between asthma and COPD [mean fold difference (95% CI): IL-8, 2.6 (1.3-5.4), p = 0.01; TNFRI, 2.1 (1.3-5.4), p = 0.03; TNFRII, 2.6 (1.2-5.6), p = 0.02]. In neutrophilic and eosinophilic airway inflammation, TNFα, TNFRI, TNFRII, IL-6, IL-8 and IL-5 could differentiate between these phenotypes. However, these phenotypes were unrelated to the diagnosis of asthma or COPD. CONCLUSION: Recovery of sputum mediators sensitive to DTT can be improved using the described sputum processing technique. Within airway inflammatory sub-phenotypes there is a differential pattern of mediator expression that is independent of disease. Whether these inflammatory phenotypes in asthma and COPD confer distinct pathogeneses, therapeutic responses and clinical phenotypes needs to be further evaluated. |
| first_indexed | 2024-03-07T00:42:00Z |
| format | Journal article |
| id | oxford-uuid:835c1f13-d9bf-45b8-8677-9441e8041b55 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:42:00Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:835c1f13-d9bf-45b8-8677-9441e8041b552022-03-26T21:43:43ZProfiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:835c1f13-d9bf-45b8-8677-9441e8041b55EnglishSymplectic Elements at Oxford2012Bafadhel, MMcCormick, MSaha, SMcKenna, SShelley, MHargadon, BMistry, VReid, CParker, DDodson, PJenkins, MLloyd, ARugman, PNewbold, PBrightling, CBACKGROUND: Asthma and chronic obstructive pulmonary disease (COPD) display features of overlap in airway physiology and airway inflammation. Whether inflammatory phenotypes in airway disease describe similar mediator expression is unknown. OBJECTIVES: To explore the relationship of airway inflammation and cytokine and chemokine expression in asthma and COPD. METHODS: Subjects with asthma and COPD (n = 54 and n = 49) were studied. Clinical characteristics and sputum were collected at entry into the study. A 2-step sputum processing method was performed for supernatant and cytospin preparation. Meso Scale Discovery and Luminex platforms were used to measure cytokines, chemokines and matrix metalloproteinase levels. RESULTS: Analytes sensitive to dithiothreitol (DTT) that had increased recovery in the 2-step sputum process were IL-1β, 4, 5, 10, 13, IFN-γ, TNFRI, GM-CSF, CCL2, 3, 4, 5, 13 and 17. There was a differential expression in IL-8, TNFRI and TNFRII between asthma and COPD [mean fold difference (95% CI): IL-8, 2.6 (1.3-5.4), p = 0.01; TNFRI, 2.1 (1.3-5.4), p = 0.03; TNFRII, 2.6 (1.2-5.6), p = 0.02]. In neutrophilic and eosinophilic airway inflammation, TNFα, TNFRI, TNFRII, IL-6, IL-8 and IL-5 could differentiate between these phenotypes. However, these phenotypes were unrelated to the diagnosis of asthma or COPD. CONCLUSION: Recovery of sputum mediators sensitive to DTT can be improved using the described sputum processing technique. Within airway inflammatory sub-phenotypes there is a differential pattern of mediator expression that is independent of disease. Whether these inflammatory phenotypes in asthma and COPD confer distinct pathogeneses, therapeutic responses and clinical phenotypes needs to be further evaluated. |
| spellingShingle | Bafadhel, M McCormick, M Saha, S McKenna, S Shelley, M Hargadon, B Mistry, V Reid, C Parker, D Dodson, P Jenkins, M Lloyd, A Rugman, P Newbold, P Brightling, C Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. |
| title | Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. |
| title_full | Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. |
| title_fullStr | Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. |
| title_full_unstemmed | Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. |
| title_short | Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. |
| title_sort | profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease |
| work_keys_str_mv | AT bafadhelm profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT mccormickm profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT sahas profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT mckennas profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT shelleym profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT hargadonb profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT mistryv profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT reidc profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT parkerd profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT dodsonp profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT jenkinsm profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT lloyda profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT rugmanp profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT newboldp profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease AT brightlingc profilingofsputuminflammatorymediatorsinasthmaandchronicobstructivepulmonarydisease |